FINTEPLA

This brand name is authorized in Estonia, Spain, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug FINTEPLA contains one active pharmaceutical ingredient (API):

1 Fenfluramine
UNII 3KC089243P - FENFLURAMINE HYDROCHLORIDE

Fenfluramine is a serotonin releasing agent, and thereby stimulates multiple 5-HT receptor sub-types through the release of serotonin. Fenfluramine may reduce seizures by acting as an agonist at specific serotonin receptors in the brain, including the 5-HT1D, 5-HT2A, and 5-HT2C receptors, and also by acting on the sigma-1 receptor. The precise mode of action of fenfluramine in Dravet syndrome and Lennox-Gastaut syndrome is not known.

Read about Fenfluramine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FINTEPLA Oral solution European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N03AX26 N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1835906, 1835917, 1835928, 1835939
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1201491001
Country: FR Base de données publique des médicaments Identifier(s): 62154820
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 397999, 398001, 398002
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9014
Country: IT Agenzia del Farmaco Identifier(s): 049286014, 049286026, 049286038, 049286040
Country: JP 医薬品医療機器総合機構 Identifier(s): 1139016S1020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1091688, 1091689, 1091690, 1091691
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100446075
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68995001, W68995002, W68995003, W68995004
Country: US FDA, National Drug Code Identifier(s): 43376-322

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.